Fuva Brain Ltd.

As of March 31, 2026, Fuva Brain Ltd. carries a market capitalization of 6.40B, placing it among publicly traded companies globally. Its enterprise value stands at 5.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Fuva Brain Ltd.'s next confirmed earnings release is scheduled for November 13, 2026.

As of March 31, 2026, Fuva Brain Ltd. has 5.34M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Fuva Brain Ltd. maintains a current ratio of 1.35, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Fuva Brain Ltd.'s stock has gained approximately 41.55% over the past 52 weeks. The 50-day moving average sits at 960.92, while the 200-day moving average is 965.17.

As of March 31, 2026, Fuva Brain Ltd. holds 2.10B in cash and equivalents against 927.01M in total debt, resulting in a net debt position of -983.97M. Total book value stands at 2.15B, with working capital of 1.07B providing operational flexibility.

Fuva Brain Ltd.'s most recent stock split took place on June 28, 2016 with a 1:2 split ratio.